Menu Search
Equities

inTest Corp

IN9:FRA

inTest Corp

Actions
  • Price (EUR)7.10
  • Today's Change-0.10 / -1.39%
  • Shares traded--
  • 1 Year change-36.04%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

inTEST Corporation is a supplier of test and process technology solutions for use in manufacturing and testing. The Company’s segments include Electronic Test, Environmental Technologies and Process Technologies. Electronic Test consists of inTEST EMS, which has operations in New Jersey and California, and Acculogic, which has operations in Canada, California and Germany. Environmental Technologies consists of inTEST Thermal Solutions (iTS), which manufactures and sells products under the Temptronic, Sigma, Thermonics and North Sciences brand names and has operations in Massachusetts, Germany and Singapore. Process Technologies consists of Ambrell, which has operations in New York, the Netherlands and the United Kingdom, and Videology, which has operations in Massachusetts and the Netherlands. Its key markets include automotive, defense/aerospace, industrial, life sciences, and security, as well as both the front-end and back-end of the semiconductor manufacturing industry.

  • Revenue in USD (TTM)121.97m
  • Net income in USD2.84m
  • Incorporated1997
  • Employees323.00
  • Location
    inTest Corp804 E Gate Dr Ste 200MOUNT LAUREL 08054-1209United StatesUSA
  • Phone+1 (856) 505-8800
  • Fax+1 (302) 421-5866
  • Websitehttps://www.intest.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		INTT:ASQ since
announced		Transaction
value
Alfamation SpADeal completed12 Mar 202412 Mar 2024Deal completed-32.26%--
Data delayed at least 15 minutes, as of Nov 13 2024 21:10 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.